Ospedale Maggiore Policlinico

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Haemophilia2 trials
• Liver and biliary tract cancer2 trials
• Lung cancer2 trials
• Alzheimer disease1 trial
• Bladder cancer1 trial
• Childhood cancers1 trial
• Diffuse large B-cell lymphoma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed3 trials
• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2 trials
• Hoffmann-La Roche2 trials
• Baxalta now part of Shire1 trial
• International Extranodal Lymphoma Study Group (IELSG)1 trial
• Octapharma1 trial

Running trials

• Recruiting

  A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

  NCT07284121· Hoffmann-La Roche· Source

• Recruiting

  MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms

  NCT07863466· Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico· Source

  Contact: Barbara Mora

• Active, not recruiting

  Functionalized Point of Care and 3D Printed Dental Aligners as Devices for Early Detection of Neurodegenerative Diseases

  NCT07870070· Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico· Source

• Recruiting

  Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

  NCT03695978· Octapharma· Source

  Contact: Elena Santangostino

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Haemophilia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

  NCT03782207· Hoffmann-La Roche· Source

• Completed

  A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

  NCT02615691· Phase 3· Baxalta now part of Shire· Source

• Completed

  New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

  NCT02329080· Phase 2· International Extranodal Lymphoma Study Group (IELSG)· Source